Toxoplasmosis acquired during pregnancy: Improved serodiagnosis based on avidity of IgG

Journal of Infectious Diseases

Volumn 167, Issue 3, 1993, Pages 691-697

  Lappalainen, Maija ^a,b   Koskela, Pentti ^a,b   Koskiniemi, Marjaleena ^a,b   Ämmälä, Pirkko ^a,b   Hiilesmaa, Vilho ^a,b   Teramo, Kari ^a,b   Raivio, Kari O ^a,b   Remington, Jack S ^a,b   Hedman, Klaus ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGGLUTINATION TEST; ANTIBODY AFFINITY; ANTIBODY TITER; ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINLAND; HUMAN; IMMUNOBLOTTING; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; SERODIAGNOSIS; TOXOPLASMOSIS;

AGGLUTINATION TESTS; ANTIBODY AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOXOPLASMOSIS;

EID: 0027535822     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/167.3.691     Document Type: Article

References (46)

1. Remington JS, Desmonts G, Toxoplasmosis, In: Remington JS, Klein JO, eds, Infectious diseases of the fetus and newborn infant, 3rd ed, Philadelphia: WB Saunders, 1990: 98-195.
2. Frenkel JK, Toxoplasmosis, Symposium on parasitic infections, Pediatr Clin North Am 1985; 32: 917-32.
3. Koppe, IG, Loewer-Sieger DH, de Roever-Bonnet H, Results of20-year follow-up of congenital toxoplasmosis, Lancet 1986; 1: 254-6.
4. Wilson CB, Remington JS, Stagno S, Reynolds OW, Development of adverse sequelae in children born with subclinical congenital toxoplasma infection, Pediatrics 1980; 66: 767-74.
5. Sever JL, Ellenberg JH, Ley AC, Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies, Pediatrics 1988; 82: 18192.
6. Daffos F, Forestier F, Capella-Pavlovsky M, Prenatal management of746 pregnancies at risk for congenital toxoplasmosis, N Engl J Med 1988; 318: 271-5.
7. Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M, Prenatal diagnosis of congenital toxoplasmosis, Lancet 1985; 1: 500-4.
8. Burg JL, Grover CM, Pouletty P, Boothroyd JC, Direct and sensitive detection ofa pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction, J Clin Microbiol 1989; 27: 1787-92.
9. Savva O, Morris JC, Johnson JD, Holliman RE, Polymerase chain reaction for detection of Toxoplasma gondii, J Med Microbiol 1990; 32: 25-31.
10. Dupouy-Camet J, deSouza SL, Bougnoux ME, Preventing congenital toxoplasmosis [letter], Lancet 1990; 2: 1018.
11. Antenatal screening for toxoplasmosis in the UK [editorial], Lancet 1990; 2: 346-8.
12. Pinon JM, Thoannes H, Gruson N, An enzyme-linked immuno-fiItration assay used to compare infant and maternal antibody profiles in toxoplasmosis, J Immunol Methods 1985; 77: 15-23.
13. Sulzer A, Franco EL, Takafuji E, Benenson M, Walls KW, Greenup RL, An oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G and M over one year, Am J Trop Med Hyg 1986; 35: 290-6.
14. Brooks RG, McCabe RE, Remington JS, Role of serology in the diagnosis of toxoplasmic lymphadenopathy, Rev Infect Dis 1987; 9: 1055-62.
15. Herbrink P, van Loon AM, Rotmans JP, van Knapen F, van Dijk WE, Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii, J Clin Microbiol 1987; 25: 100-5.
16. Del Bono V, Canessa A, Bruzzi P, Fiorelli MA, Terragna A, Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy, J Clin Microbiol 1989; 27: 2133-5.
17. Turunen H, Vuorio KA, Leinikki PO, Determination of lgG, IgM and IgA antibody responses in human toxoplasmosis by enzyme-linked immunosorbent assay (ELISA), Scand J Infect Dis 1983; 15: 307-11.
18. Stepick-Biek P, Thulliez P, Araujo FG, Remington JS, IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis, J Infect Dis 1990; 162: 270-3.
19. Decoster A, Caron A, Darcy F, Capron A, IgAantibodies against P30 as markers of congenital and acute toxoplasmosis, Lancet 1988; 2: 1104-7.
20. Pinon JM, Thoannes H, Pouletty PH, Poirriez J, Damiens J, Pelletier P, Detection ofigA specific for toxoplasmosis in serum and cerebrospinal fluid using non-enzymatic IgA-capture assay, Diagn Immunol 1986; 4: 223-7.
21. Fortier B, Rolland O, Ajana F, Dubremetz JF, Vernes A, Detection of specific antibodies to Toxoplasma gondii by a competitive enzyme immunoassay using a monoclonal antibody against the P30 antigen, Eur J Clin Microbiol Infect Dis 1991; 10: 38-40.
22. Decoster A, Slizewicz B, Simon J, Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection ofanti-P30 immunoglobulin A antibodies, J Clin Microbiol 1991; 29: 2291-5.
23. Suzuki Y, Thulliez P, Remington JS, Use of acute-stage-specific antigens of Toxoplasma gondii for serodiagnosisof acute toxoplasmosis, J Clin Microbiol 1990; 28: 1734-8.
24. Dannemann BR, Vaughan WE, Thulliez P, Remington JS, Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii, J Clin Microbiol 1990; 28: 1928-33.
25. Suzuki Y, Thulliez P, Desmonts G, Remington JS, Antigen(s) responsible for immunoglobulin G responses specific for the acute stage of toxoplasma infection in humans, J Clin Microbiol 1988; 26: 901-5.
26. Pinon JM, Toubas O, Marx C, Detection of specificimmunoglobulin E in patients with toxoplasmosis, J Clin Microbiol 1990; 28: 1739-43.
27. Hedman K, Lappalainen M, Seppala I, Makela O, Recent primary toxoplasma infection indicated by a low avidity of specific IgG, J Infect Dis 1989; 159: 736-40.
28. Joynson OHM, Payne RA, Rawal BK, Potential role ofigG avidity for diagnosing toxoplasmosis, J Clin Pathol 1990; 43: 1032-3.
29. Hedman K, Seppala I, Recent rubella virus infection indicated by a low avidity of specific IgG, J Clin Immunol 1988; 8: 214-21.
30. Rousseau S, Hedman K, Rubella infection and reinfection distinguished by avidity ofigG [letter], Lancet 1988; 1: 1108-9.
31. Hedman K, Vaheri A, Brummer-Korvenkontio M, Rapid diagnosis of hantavirus disease with an IgG-avidity assay, Lancet 1991; 338: 1353-6.
32. Pullen GR, Fitzgerald MG, Hosking CS, Antibody avidity determination by ELISA using thiocyanate elution, J Immunol Methods 1986; 86: 83-7.
33. Enders G, Knotek F, Rubella IgG total antibody avidity and IgG subclass specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection, Infection 1989; 17: 218-26.
34. Thomas HIJ, Morgan-Capner P, The use ofantibody avidity measurements for the diagnosis of rubella, Rev Med Virol 1991; 1: 41-50.
35. Lappalainen M, Koskela P, Hedman K, Incidence of primary toxoplasma infections during pregnancy in southern Finland, A prospective cohort study, Scand J Infect Dis 1992; 24: 97-104.
36. Joss AWL, Skinner U, Chatterton JMW, Cubie HA, Pryde JFD, Campbell JD, Toxoplasmosis: effectiveness of enzyme immunoassay screening, Med Lab Sci 1989; 46: 107-12.
37. Joynson OHM, Payne RA, Balfour AH, Prestage ES, Fleck DG, Five commercial enzyme linked immunosorbent assay kits for toxoplasma specific IgM antibody, J Clin Pathol 1989; 42: 653-7.
38. Balfour AH, Harford JP, Detection of specific IgG and IgM antibodies to Toxoplasma gondii with a commercially available enzyme immunoassay kit system, J Clin Pathol 1985; 38: 679-89.
39. Verhofstede C, van Renterghem, Plum J, Comparison of six enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii, J Clin Pathol 1989; 42: 1285-90.
40. Partanen P, Turunen H, Paasivuo R, Leinikki P, Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulins G, M, and A antibodies at different stages of infection, J Clin Microbiol 1984; 20: 133-5.
41. Potasman J, Araujo FG, Thulliez P, Desmonts G, Remington JS, Toxoplasma gondii antigens recognized by sequential samples of serum obtained from congenitally infected infants, J Clin Microbiol 1987; 25: 1926-31.
42. Deletoille P, Ovlaque G, Slizewicz B, Advantage of using 35,000-molecular-weight protein for testing of Toxoplasma gondii immunoglobulin M [letter], J Clin Microbiol 1988; 26: 796-7.
43. Potasman I, Araujo FG, Remington JS, Toxoplasma antigens recognized by naturally occurring human antibodies, J Clin Microbiol 1986; 24: 1050-4.
44. Sharma SO, Mullenaux J, Araujo FG, Erlich HA, Remington JS, Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies, J Immunol 1983; 131: 977-83.
45. Camargo ME, da Silva SM, Leser PG, Granato CH, Avidez de anticorpos IgG especificos como marcadores de infeccao primaria recente pelo Toxoplasma gondii, Rev Inst Med Trop Sao Paulo 1991; 33: 213-8.
46. Thorp JM, Seeds JW, Herbert WNP, Prenatal management and congenital toxoplasmosis [letter], N Engl J Med 1988; 319: 372-3.